Our IVD (In-Vitro Diagnostics) design approach starts from a scientific and medical perspective. That approach is the basis of our innovation and differentiates our device from others. Of course, we can – like others – imitate and automate the lab test and call it a rapid test, but we are not an automation company.
We focus on innovation. That is where our science makes a difference.
What is a virus?
There are billions of viruses around us; we breathe them, drink, eat, and constantly have some degree of contact with surfaces. All those consist of viruses.
According to scientific assumptions, we encounter numerous viruses, bacteria, and fungi daily. Yet, despite all of those, we are not constantly infected. Contrary to custom belief, this has nothing to do with our sophisticated immune system (our immune system kicks in after getting infected).
There are specific biochemical pathways by which genetic variants cause disease.
A virus is a parasite; it requires a host to reproduce. Therefore, the medical definition of infection is once the virus replicates inside the host.
Replicating a virus requires using the host’s replication systems inside the cell – viruses penetrate cells using the infusing process – either by a matching receptor or endocytotic pathway.
Once penetration completes, the cell releases some amino compounds in the replication process. Those amino compounds are biomarkers our technology is capable of identifying.
Where there is smoke, there is fire. So the question is what we consider as smoke.
In an RNA segment in the nasal chambers, a lab technician must replicate numerous cycles to identify if a virus statistically is there.
Or are the signs of infections the host body releases and analyzes without a “human factor”?
Is being a “carrier” of virus RNA on the body surface enough evidence to conclude sickness?
Or diagnostics at cell levels of the actual infection process, based on scientific research of virology?